Table 3. CBDDIN topological cluster labeling for each of the nine communities.
| Comm. | Colors | No. | Conf. by mod. [%] | Expl. by propr. [%] | Not expl. [%] |
|---|---|---|---|---|---|
| I | LB, VM | 80 | 77 | 19 | 4 |
| II | VM, GB, G, DB, LB, M | 271 | 80 | 8 | 12 |
| III | DB, M, LB, GB | 307 | 84 | 12 | 4 |
| IV | M, GB, G, DB | 81 | 51 | 22 | 27 |
| V | GB | 54 | 33 | 63 | 4 |
| VI | GB, G, LB, M, P | 125 | 35 | 38 | 27 |
| VII | LB | 58 | 26 | 31 | 43 |
| VIII | P, G, LB, GB | 69 | 56 | 9 | 35 |
| IX | G, LB | 96 | 30 | 57 | 13 |
| 1141 | 63 | 22 | 15 |
The modularity classes (represented by colors) confirming the community tag are listed in the second column. The third column contains the total number of drugs (No.) for each community (Comm.), which is then apportioned to the following cases: properly described by the assigned modularity class (Conf. by mod.), explained by properties taken from drug databases and literature review (Expl. by propr.), and not explained (Not expl.).